Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sandra López Peraita
Observed name:
S. López Peraita
Institution:
Hospital Universitario de Burgos
Observed institution:
Hospital Universitario de Burgos
ORCID:
0000-0002-7426-109X
Observed ORCID:
0000-0002-7426-109X
OpenAlex ID:
A5093809325
RENO Study: Clinical characteristics, treatment patterns and survival results in patients with metastatic renal cell carcinoma in Northern Spain
2024
·
Laura Basterretxea Badiola
, Nuria Lainez Milagro
, et al.
·
Seminars in Oncology
·
3
Real-world management and outcomes of patients with hepatocellular carcinoma treated with systemic therapy in Spain: a patient cohort from the RETUD gastrointestinal registry
2025
·
Carlos López-López
, Eva Martínez de Castro
, et al.
·
Clinical & Translational Oncology
·
2
PDF
Real-world outcomes and prognostic factors of trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer: a multicenter study in Spain
2026
·
N. Martínez-Lago
, M. Reboredo López
, et al.
·
ESMO Gastrointestinal Oncology
·
1
Long-term responders to trifluridine/tipiracil plus bevacizumab in previously treated metastatic colorectal cancer: Results from the BeTAS real-world study.
2026
·
Nieves Martinez Lago
, Margarita Reboredo Lopez
, et al.
·
Journal of Clinical Oncology
·
1
Single-center analysis on a real-world cohort of patients with metastatic urothelial carcinoma studied by NGS: Molecular landscape and efficacy of targeted therapies.
2024
·
César Gutiérrez Pérez
, Inmaculada Rodríguez Ledesma
, et al.
·
Journal of Clinical Oncology
·
1
Show more works
View as search
Works count:
5
Citation count:
8
H-index:
2
I10-index:
Year
Topic
Type